Bifid Triple Viable Capsules(Jincheng Haisi)

双歧杆菌三联活菌肠溶胶囊(海斯制药)

Report date: 2022/09/27 17:03:30

Base Information

Drug NameBifid Triple Viable Capsules(Jincheng Haisi)
Drug Alias NameN/A
ClassificationNatural product/Extract > Microbial extractBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsDyspepsiaDiarrheaConstipation
Global Approved IndicationsDyspepsiaDiarrheaConstipation
Approved Indications in ChinaDyspepsiaDiarrheaConstipation
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDyspepsiaDiarrheaConstipation
Inactive IndicationsN/A

Other Information

ATC CodeA07FA
Related LinksN/A